PRKCB and B-cell chronic lymphocytic leukemia: Derepression of gene expression may also explain the high levels of PKCβII in CLL cells, and in this respect a recent study demonstrated that active STAT3 can interact with the PRKCB promoter to suppress expression of this gene in myeloid cells23.